Acalculous cholecystitis is a common extrahepatic manifestation of hepatitis E and suggests a more serious conditionArticle Published on 2023-04-242023-06-11 Journal: Virology Journal [Category] E형 간염, Fulltext, [키워드] Acalculous cholecystitis hepatitis E Hospital stay Spontaneous peritonitis. [DOI] 10.1186/s12985-023-02045-8 PMC 바로가기
Global reports of takotsubo (stress) cardiomyopathy following COVID-19 vaccination: A systematic review and meta-analysisReview article Published on 2022-12-012022-10-05 Journal: IJC Heart & Vasculature [Category] 바이오마커, [키워드] addition age average BNT162b2 Broken heart syndrome Cardiomyopathy Case report ChAdOx1 nCoV-19 Complication concern conducted COVID-19 COVID-19 vaccinations COVID-19 vaccine COVID-19 vaccines ECG Ejection fraction elevated female first dose Google Scholar Hospital stay individual life-threatening LVEF male Messenger RNA Meta-analysis mRNA mRNA vaccine mRNA-1273 occurred onset of symptom Pain participated Patient patients raised receiving second dose Stress Stress cardiomyopathy Symptom Symptoms systematic literature search systematic review Takotsubo cardiomyopathy TCM the mean the patient troponin test vaccination Vaccines ventricular Web of Science with COVID-19 [DOI] 10.1016/j.ijcha.2022.101108 [Article Type] Review article
Effect of colchicine on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomised controlled trialsCOVID-19 환자의 결과에 대한 콜히친의 영향: 무작위 대조 시험의 체계적인 검토 및 메타 분석Meta-Analysis Published on 2022-12-012022-09-11 Journal: Annals of Medicine [Category] 임상, [키워드] 95% CI addition adverse event adverse events Clinical efficacy clinical outcomes ClinicalTrials Cochrane Library Colchicine control group COVID-19 database diarrhoea Effect higher risk hospital Hospital stay improve clinical outcome mean difference mechanical ventilation Meta-analysis Mortality no significant difference non-invasive ventilation non-invasive ventilation. not reduce Odds ratio outcome OVID Patient patients with COVID-19 Placebo placebos randomised controlled trial RCT RCTs receiving risk SARS-CoV-2 searched significant difference significantly higher standard treatment study group Support systematic review the study group Treatment Web of Science [DOI] 10.1080/07853890.2022.2096919 PMC 바로가기 [Article Type] Meta-Analysis
Influenza and pneumococcal vaccination and COVID-19 in kidney transplant patientsResearch article Published on 2022-12-012022-10-05 Journal: Transplant immunology [Category] 변종, 진단, 치료제, [키워드] addition administration benefit Clinical course control group COVID COVID-19 COVID-19 infection disease Donor dysfunction examined follow-up time group Hospital stay Hospitalization increased the risk Influenza Influenza and pneumoccal vaccine intensive care kidney transplant kidney transplant recipient lack Logistic regression analysis median multivariate need for dialysis no significant difference observation outcome pandemic Patient pneumococcal positive recipient reduce Result risk of COVID-19 rRT-PCR test significantly higher the disease the patient vaccination vaccination rate Vaccine Vaccines with COVID-19 [DOI] 10.1016/j.trim.2022.101693 [Article Type] Research article
Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestationsArticle Published on 2022-11-012022-11-15 Journal: Journal of Neurology [Category] COVID19(2023년), SARS, 바이오마커, [키워드] absence Admission baseline Biomarker Blood Brescia C-reactive protein change controls correlated COVID-19 CRP D-dimer disease severity evaluated Evidence excluded explained fibrinogen healthy controls Hospital stay Hospitalized hypoxic Increased longitudinal measure Neuroaxonal damage neurofilament Neurofilament light chain (NFL) neurological manifestation neurological manifestations neurotoxic PaO2/FiO2 ratio parameters Patient patients plasma promote reported respiratory respiratory impairment SARS-CoV-2 scale serum serum creatinine serum CRP Serum level serum sample serum. significantly Simoa systemic inflammation Variation were measured White blood cell with mild disease [DOI] 10.1007/s00415-022-11233-5 PMC 바로가기
The safety of esophageal cancer surgery during COVID-19Article Published on 2022-10-142022-11-16 Journal: Medicine [Category] meta-analysis, [키워드] 95% confidence interval anastomotic Blood Cancer Chinese Cochrane Library complications conducted coronavirus disease COVID-19 COVID-19 pandemic database determine evaluate Evidence Fang heterogeneity Hospital stay ICU identify Infrastructure intensive care journal mean difference Meta-analysis Mortality outcome outcomes pandemic Patient postoperative Primary outcome random effect model readmission Registered researchers risk risk ratio secondary outcome surgical systematic review Trial was performed Web of Science were used [DOI] 10.1097/MD.0000000000030929 PMC 바로가기
Incidence of COVID-19 and Identification of Possible Risk Factors Associated with COVID-19 in Acute Renal Transplant Recipients in PakistanArticle Published on 2022-10-042022-11-15 Journal: Annals of transplantation [Category] COVID19(2023년), SARS, 진단, [키워드] acquisition age baseline Characteristics Comorbidities Compliance COVID-19 COVID-19 disease Diabetes Mellitus enrolled Factor female gender Follow-up Gender Health status hospital Hospital stay identification identify immunosuppressive therapies incidence increased mortality Infection males management measure Measures overall mortality Patient patients Protective questionnaire raised recipient recipients renal required risk factor Risk factors SARS-COV-2 infection serum creatinine susceptible symptomatic Transplant transplants with COVID-19 [DOI] 10.12659/AOT.937688 PMC 바로가기
Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 delta and omicron variants중증급성호흡기증후군 코로나바이러스 2 델타 및 오미크론 변이체에 대한 단일클론항체의 임상적 효능 및 시험관내 중화능Article Published on 2022-10-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Casirivimab casirivimab/imdevimab clinical Concentration coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient decrease delta variant dosage Efficacy except for exhibit Hospital stay Imdevimab in vitro in vitro data in vivo Infection mAb mAbs monoclonal monoclonal antibodies monoclonal antibody neutralization Neutralization assay neutralization capacity neutralizing capacity neutralizing effect Omicron variant Patient patients treated performed provided receiving respiratory respiratory tract respiratory viral RNA SARS-CoV-2 SARS-CoV-2 delta SARS-CoV-2 RNA severe acute respiratory syndrome Coronavirus sotromivab Sotrovimab the SARS-CoV-2 therapeutic therapy treated variant Viral Virus neutralization virus neutralization assay. virus neutralization assays [DOI] 10.1002/jmv.27916 PMC 바로가기 [Article Type] Article
Clinical prediction models in hospitalized patients with COVID-19: A multicenter cohort studyArticle Published on 2022-10-012022-11-15 Journal: Respiratory medicine [Category] 진단, [키워드] Accuracy acute COVID-19 Admission age APACHE II asymptomatic infection calculated Care clinical Clinical decision rules COVID-19 COVID-GRAM Critical CURB-65 death died Hospital stay Hospitalized hospitalized patient IMPROVE In-hospital death independent predictor intubation Italian majority Mortality multicenter cohort study Negative predictive value novel coronavirus disease outbreak PaO2/FiO2 ratio Patient patients with COVID-19 Pneumonia Positive predictive value predict predictor Prognosis prognostic risk SARS-CoV-2 SARS-CoV-2. Sepsis severe respiratory failure SOFA [DOI] 10.1016/j.rmed.2022.106954 PMC 바로가기
Characterization of coagulopathy and outcomes in cancer patients with severe COVID -19 illness: Longitudinal changes in hospitalized cancer patientsArticle Published on 2022-10-012022-11-15 Journal: Cancer Medicine [Category] COVID19(2023년), SARS, 바이오마커, [키워드] 1:1 Anderson blood cell count Cancer cancer patient Cancer patients CBC center change changes in characterization clinical clinical observations Coagulopathy Complete correlated COVID COVID-19 COVID-19 illness COVID-19 patient Critical CRP death disease elevated feature fibrinogen FIVE future risk had more help hematological hematological cancer Hospital admission Hospital stay Hospitalization Hospitalized IL-6 inflammatory markers interleukin-6 lack longitudinal Lymphocyte count management measure mechanical ventilation mechanism Mortality neutrophil Non-COVID-19 outcome outcomes Peripheral blood Platelet prognostic Prognostic factor required Retrospective analysis risk Risk assessment Serum ferritin severe COVID-19 illness Stratification survival thrombosis Thrombotic complications unique viral infection Viral infection. with COVID-19 [DOI] 10.1002/cam4.4753 PMC 바로가기